ESG

Net zero and life-science real estate: Easier said than done

By July/August 2022 (Magazine)

AstraZeneca campus, Cambridge

Investors are piling into the burgeoning life-science real estate sector, but they might have underestimated the net-zero challenge involved, writes Gary Clark

You need to be a registered user to read this content

Already a registered user or subscriber? Sign in here

To continue reading, register today for access

Register today

Registration also includes access to

IPE

Gated access promo

Five reasons to register today

  1. Access IPE Real Assets articles
  2. Daily news alerts and updates
  3. Track what the world’s leading institutional investors are doing
  4. Learn about the latest industry research and market analysis
  5. Comprehensive archive of data and intelligence on investors and fund managers